Dr Carlos Echevarria
| Optimising outcomes for adults with cystic fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework | 2025 |
|
Khadeija Almarshoodi
Dr Carlos Echevarria
Professor Christopher Ward
| An International Validation of the "DECAF Score" to Predict Disease Severity and Hospital Mortality in Acute Exacerbation of COPD in the UAE | 2024 |
|
Dr Carlos Echevarria
Professor Anthony De Soyza
| Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study | 2024 |
|
Dr Encarna Mico Amigo
Dr Cameron Kirk
Dr Lisa Alcock
Philip Brown
Dr Carlos Echevarria
et al. | Real-world gait detection using a wrist-worn inertial sensor: Validation study | 2024 |
|
Dr Cameron Kirk
Dr Philip Brown
Dr Carlos Echevarria
Professor Alison Yarnall
Professor Lynn Rochester
et al. | Real-world gait detection using a wrist-worn inertial sensor: validation study | 2024 |
|
Dr Laura McGowan
Dr Fiona Graham
Jan Lecouturier
Dr Carlos Echevarria
Professor Falko Sniehotta
et al. | The Views and Experiences of Integrated Care System Commissioners About the Adoption and Implementation of Virtual Wards in England: Qualitative Exploration Study | 2024 |
|
Professor Stephen Bourke
Dr Simon Doe
Dr Carlos Echevarria
| Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331, (J Cyst Fibros (2022), 21/2(323-331) (S1569199321014089), (10.1016/j.jcf.2021.09.007)) | 2022 |
|
Dr Carlos Echevarria
Dr Simon Doe
Dr Malcolm Brodlie
Professor Christopher Ward
Dr Stephen Bourke
et al. | Elexacaftor-Tezacaftor-Ivacaftor improve Gastro-Oesophageal reflux and Sinonasal symptoms in advanced cystic fibrosis | 2022 |
|
David Langton
Professor Stephen Bourke
Dr Rebecca Darlay
Dr Carlos Echevarria
| The influence of HLA genotype on the severity of COVID-19 infection | 2021 |
|
Professor Stephen Bourke
Dr Simon Doe
Dr Carlos Echevarria
| Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis | 2021 |
|
Dr Carlos Echevarria
Dr John Steer
Dr Tom Hartley
Dr Nicholas Lane
Professor Stephen Bourke
et al. | Predictors of NIV Treatment in Patients with COPD Exacerbation Complicated by Respiratory Acidaemia | 2020 |
|
Dr Carlos Echevarria
Dr John Steer
Professor Stephen Bourke
| Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score | 2019 |
|
Dr Christine Baker
Dr Debbie Carrick-Sen
Emerita Professor Julia Newton
Dr Carlos Echevarria
Dr Chris Stenton
et al. | Randomised controlled trial of cognitive behavioural therapy in COPD | 2018 |
|
Dr Carlos Echevarria
Dr John Steer
Professor Stephen Bourke
| Prognostic Value of Platelet Count in Patients Admitted with an Acute Exacerbation of COPD (AECOPD) | 2014 |
|
Dr Carlos Echevarria
Dr John Steer
Emeritus Professor John Gibson
Professor Stephen Bourke
| Red Cell Distribution Width as a Predictor of Hospital Mortality in Acute Exacerbations of COPD (AECOPD) | 2014 |
|
